- PLN2.80bn
- PLN2.76bn
- PLN681.30m
Brief: Synektik Estimates Non-Cash Gain Of About 261 Mln Zlotys From Syn2bio Spin-Off
Brief: Synektik Unit Signs EUR 3.7 Mln Deals For Delivery Of Da Vinci System With Hospital In Czech Republic
Brief: Synektik Estimates H1 Consolidated Revenue At About 441 Million Zlotys
Syn2bio shares halted at Warsaw Stock Exchange debut
Brief: Synektik Secures Orders Worth About 163 Million Zlotys In Q2
Brief: Synektik Signs 30.0 Mln Zloty Deals For Delivery Of Da Vinci System
Brief: Synektik Signs 21.2 Mln Zloty Deals With University Clinical Center In Gdansk For Da Vinci 5 System
Brief: Synektik Says KNF Approves Syn2bio Prospectus For Spin-Off
Brief: Synektik Signs Deal With Hospital In Grudziadz For Da Vinci System
Brief: Synektik Q1 Net Profit At 35.0 Million Zlotys
Brief: Synektik To Transfer Organized Part Of Enterprise Related To Cardiomarker And CBNC To Syn2bio
Brief: Synektik Expands And Extends Distribution Agreement With Intuitive Surgical
Brief: Synektik Signs 18.3 Mln Zloty Deal For Delivery For Da Vinci System
Brief: Synektik Signs 18.5 Mln Zloty Deal With University Hospital In Szczecin For Delivery Of Da Vinci System
Brief: Synektik Unit Signs $3.0 Mln Deal For Da Vinci System Delivery With Ostrava City Hospital
Brief: Synektik Q1 Medical Equipment Orders Value At 148 Mln Zlotys
Brief: Synektik Signs 13.1 Mln Zlotys Contract With Hospital In Włocławek For Da Vinci Robotic System
Brief: Synektik Signs Deal For Distribution Of Cancer Therapy Equipment
Brief: Synektik Signs 20.8 Mln Zloty Deal For Delivery Of Da Vinci System